Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Aspen Aerogels Inc (ASPN) vs Marsh & McLennan Companies, Inc. (MRSH) Price & Performance

Aspen Aerogels IncTrade
Marsh & McLennan Companies, Inc.Trade

Price performance (Past 24H)

Key statistics

Aspen Aerogels Inc vs Marsh & McLennan Companies, Inc. — how do they compare? Aspen Aerogels Inc trades at $6.15 (market cap $509.55M), while Marsh & McLennan Companies, Inc. trades at $188.29 (market cap $91.27B). The key difference: Marsh & McLennan Companies, Inc. is far larger — about 179.1× Aspen Aerogels Inc's market cap, and Marsh & McLennan Companies, Inc. pays a 2.07% dividend while Aspen Aerogels Inc pays none. Which is the better fit depends on your goals.

ASPNMRSH
Market Cap
$509.55M$91.27B
Sector
TechnologyFinancials
52-Week High
$8.82$211.21
52-Week Low
$2.57$157.32
Enterprise Value
$482.96M$111.95B
Dividend Yield
2.07%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Aspen Aerogels Inc

Aspen Aerogels (ASPN) trades at $6.13, down 2.54% today, with a bullish technical signal from moving averages despite mixed oscillators. The company shows improving revenue trends with Q2 2026 results beating expectations and strong Q3 guidance of $65-80 million revenue. However, profitability remains challenged with negative net income margins of -62.45% and consecutive quarterly EPS misses. Analyst sentiment is overwhelmingly positive with 82.61% buy ratings.

The outlook balances strong revenue growth potential in thermal barrier markets against persistent profitability challenges. Investment opportunity lies in the expanding EV thermal barrier business and European market growth, while risks include sustained negative cash flow and competitive pressures in evolving battery technologies.

Marsh & McLennan Companies, Inc.

Marsh & McLennan (MRSH) trades at $189.13, down 0.87% on the day, with a bullish technical signal and strong fundamental performance. Recent earnings beats in Q2 2026, with EPS of $2.96 versus $2.88 expected, and 6% revenue growth highlight operational strength. The company announced the acquisition of Accel to expand its Midwest insurance reach, signaling strategic growth. Valuation metrics show a P/E of 23.35 and robust profitability with a net income margin of 14.24%.

The outlook remains positive with a consensus price target of $202.89, offering potential upside. Risks include margin pressure from rising expenses and soft P&C pricing. Institutional activity is mixed, with Bank of America reducing its stake while others like Bank of Nova Scotia increased holdings. The stock presents a solid long-term growth opportunity amid cyclical insurance sector headwinds.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Aspen Aerogels Inc

Aspen Aerogels is an aerogel technology company that designs high-performance insulation. Its products are used in energy infrastructure and electric vehicles to provide thermal management and fire protection.

Read more on ASPN

About Marsh & McLennan Companies, Inc.

Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).

Read more on MRSH